Evidence map›Paper›PMID 29693015›Full record

ArticleBioMed research international2018

Elevated TERT Expression in TERT-Wildtype Adult Diffuse Gliomas: Histological Evaluation with a Novel TERT-Specific Antibody.

Kenta Masui, Takashi Komori, Yukinari Kato, Kenkichi Masutomi, Koichi Ichimura, Satoshi Ogasawara, Mika K Kaneko, Hiroharu Oki, Hiroyoshi Suzuki, Masayuki Nitta and 5 more

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BioMed research international, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Article
  3. Detection ofBiomedicines · 2022
    Review
  4. TERT expression increases with tumor grade in a cohort ofAmerican journal of translational research · 2022
    Article
  5. A Qualitative Signature to IdentifyFrontiers in molecular biosciences · 2022
    Article
  6. Article
  7. GRPEL2 Knockdown Exerts Redox Regulation in Glioblastoma.International journal of molecular sciences · 2021
    Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 1 country.

Kenta MasuiDepartment of Pathology, Tokyo Women's Medical University, Tokyo 162-8666, Japan.
Takashi KomoriDepartment of Neuropathology, Tokyo Metropolitan Neurological Hospital, Tokyo 183-0042, Japan.ORCID 0000-0002-6812-2149
Yukinari KatoDepartment of Antibody Drug Development, Tohoku University Graduate School of Medicine, Miyagi 980-8575, Japan.
Kenkichi MasutomiDivision of Cancer Stem Cell, National Cancer Center Research Institute, Tokyo 104-0045, Japan.
Koichi IchimuraDivision of Brain Tumor Translational Research, National Cancer Center Research Institute, Tokyo 104-0045, Japan.
Satoshi OgasawaraDepartment of Antibody Drug Development, Tohoku University Graduate School of Medicine, Miyagi 980-8575, Japan.
Mika K KanekoDepartment of Antibody Drug Development, Tohoku University Graduate School of Medicine, Miyagi 980-8575, Japan.
Hiroharu OkiDepartment of Antibody Drug Development, Tohoku University Graduate School of Medicine, Miyagi 980-8575, Japan.
Hiroyoshi SuzukiDepartment of Pathology and Laboratory Medicine, Sendai Medical Center, Miyagi 983-0045, Japan.
Masayuki NittaDepartment of Neurosurgery, Tokyo Women's Medical University, Tokyo 162-8666, Japan.
Takashi MaruyamaDepartment of Neurosurgery, Tokyo Women's Medical University, Tokyo 162-8666, Japan.
Yoshihiro MuragakiDepartment of Neurosurgery, Tokyo Women's Medical University, Tokyo 162-8666, Japan.
Takakazu KawamataDepartment of Neurosurgery, Tokyo Women's Medical University, Tokyo 162-8666, Japan.
Tatsuo SawadaDepartment of Pathology, Tokyo Women's Medical University, Tokyo 162-8666, Japan.
Noriyuki ShibataDepartment of Pathology, Tokyo Women's Medical University, Tokyo 162-8666, Japan.
Tokyo Women's Medical University · JPTohoku University · JPNational Cancer Centre Japan · JPSendai Medical Center · JPTokyo Metropolitan Neurological Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Telomerase reverse transcriptase (TERT) is important for the biology of diffuse gliomas.

Indexed as

AnimalsBiomarkers, TumorBrainBrain NeoplasmsCell Line, TumorGlioblastomaGliomaHumansIsocitrate DehydrogenaseMice, Inbred BALB CMutationOligodendrogliomaPromoter Regions, GeneticTelomeraseBiomarkers, TumorIsocitrate DehydrogenaseTelomeraseTERT protein, human

Identifiers

PMID29693015
PMCPMC5859900
OpenAlexW2789688568

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.